Etomidate in the control of severe Cushing's syndrome by neuroendocrine carcinoma

Clin Case Rep. 2018 Mar 12;6(5):851-854. doi: 10.1002/ccr3.1478. eCollection 2018 May.

Abstract

Etomidate is a very effective drug in severe Cushing's syndrome that is refractory to ketoconazol. Control of the serum cortisol levels in ectopic Cushing's syndrome can be obtained with infusion rates much lower than those used in anesthesia, without respiratory side effects.

Keywords: Ectopic Cushing's syndrome; etomidate; metastatic carcinoma; octreoscan.

Publication types

  • Case Reports